Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

Gilead Sciences delivered a better-than-expected second quarter, propelled by the strong performance of its HIV portfolio and ...

According to the latest study from BCC Research, "Global Markets for Infectious Disease Treatments" is expected to grow from ...